Loui Madakamutil

Loui Madakamutil

Company: Nektar Therapeutics

Job title: Senior Vice President & Head of Discovery & Preclinical Development


Supercharging the Tumor Microenvironment with the Engineered Cytokines NKTR-214 & KNTR-255 3:00 pm

• The idea of combining the immune modulating properties of checkpoint inhibitors and other immunological medicines with the immune stimulating function of engineered cytokines is conceptually powerful • Engineered cytokines can more effectively stimulate cytokine receptor pathways, while controlling adverse events • The combination of NKTR-214 with Opdivo has demonstrated powerful anti-tumor effects and profoundly…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.